Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

USE OF THIOBARBITAL IN THE TREATMENT OF HYPERTHYROIDISM

USE OF THIOBARBITAL IN THE TREATMENT OF HYPERTHYROIDISM Astwood1 has reported that diethyl thiobarbituric acid (thiobarbital) has antithyroid activity similar to that of thiouracil. Experiments on rats showed that thiobarbital in small doses was somewhat more effective in inhibiting thyroid function and perhaps less toxic than thiouracil. In larger doses, however, animals receiving thiobarbital were noted to have fatty infiltration of the liver. Astwood has been using thiobarbitol in clinical hyperthyroidism since February 1944 and has made a report on his results.1a The opportune moment for our initial trial use of thiobarbital came in October 1944 when a patient receiving thiouracil developed a fever reaction necessitating discontinuance of treatment and in whom further antithyroid therapy was thought essential before thyroidectomy. This first patient to receive thiobarbital (chart 1) was an extremely fragile woman aged 75 with severe hyperthyroidism of five years' duration due to an adenomatous goiter. She weighed 83 pounds (37.6 Kg.) and had a http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

USE OF THIOBARBITAL IN THE TREATMENT OF HYPERTHYROIDISM

JAMA , Volume 129 (14) – Dec 1, 1945

Loading next page...
 
/lp/american-medical-association/use-of-thiobarbital-in-the-treatment-of-hyperthyroidism-HWH1rCT1Ea

References (3)

Publisher
American Medical Association
Copyright
Copyright © 1945 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1945.02860480012003
Publisher site
See Article on Publisher Site

Abstract

Astwood1 has reported that diethyl thiobarbituric acid (thiobarbital) has antithyroid activity similar to that of thiouracil. Experiments on rats showed that thiobarbital in small doses was somewhat more effective in inhibiting thyroid function and perhaps less toxic than thiouracil. In larger doses, however, animals receiving thiobarbital were noted to have fatty infiltration of the liver. Astwood has been using thiobarbitol in clinical hyperthyroidism since February 1944 and has made a report on his results.1a The opportune moment for our initial trial use of thiobarbital came in October 1944 when a patient receiving thiouracil developed a fever reaction necessitating discontinuance of treatment and in whom further antithyroid therapy was thought essential before thyroidectomy. This first patient to receive thiobarbital (chart 1) was an extremely fragile woman aged 75 with severe hyperthyroidism of five years' duration due to an adenomatous goiter. She weighed 83 pounds (37.6 Kg.) and had a

Journal

JAMAAmerican Medical Association

Published: Dec 1, 1945

There are no references for this article.